As of Mar 22
| -0.19 / -2.87%|
The 8 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 17.75, with a high estimate of 34.00 and a low estimate of 13.00. The median estimate represents a +176.48% increase from the last price of 6.42.
The current consensus among 8 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.